Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Payables (2020 - 2023)

Historic Payables for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $3.3 million.

  • Terns Pharmaceuticals' Payables rose 5878.7% to $3.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $3.3 million, marking a year-over-year increase of 5878.7%. This contributed to the annual value of $1.6 million for FY2022, which is 2262.46% down from last year.
  • As of Q3 2023, Terns Pharmaceuticals' Payables stood at $3.3 million, which was up 5878.7% from $5.5 million recorded in Q2 2023.
  • In the past 5 years, Terns Pharmaceuticals' Payables ranged from a high of $5.5 million in Q2 2023 and a low of $935000.0 during Q4 2020
  • Its 4-year average for Payables is $2.4 million, with a median of $1.9 million in 2021.
  • Its Payables has fluctuated over the past 5 years, first crashed by 6051.76% in 2022, then surged by 46906.47% in 2023.
  • Terns Pharmaceuticals' Payables (Quarter) stood at $935000.0 in 2020, then surged by 127.38% to $2.1 million in 2021, then dropped by 22.62% to $1.6 million in 2022, then soared by 102.13% to $3.3 million in 2023.
  • Its last three reported values are $3.3 million in Q3 2023, $5.5 million for Q2 2023, and $2.7 million during Q1 2023.